Example of Rheumatology International format
Recent searches

Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format Example of Rheumatology International format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Rheumatology International — Template for authors

Publisher: Springer
Categories Rank Trend in last 3 yrs
Rheumatology #27 of 56 down down by 3 ranks
Immunology and Allergy #103 of 182 up up by 8 ranks
Immunology #126 of 202 up up by 5 ranks
journal-quality-icon Journal quality:
Good
calendar-icon Last 4 years overview: 993 Published Papers | 3965 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 15/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access
recommended Recommended

BMJ Publishing Group

Quality:  
High
CiteRatio: 28.7
SJR: 6.333
SNIP: 4.294
open access Open Access

Taylor and Francis

Quality:  
High
CiteRatio: 8.4
SJR: 2.078
SNIP: 1.475
open access Open Access
recommended Recommended

Nature

Quality:  
High
CiteRatio: 53.9
SJR: 20.529
SNIP: 8.97
open access Open Access

Frontiers Media

Quality:  
High
CiteRatio: 8.1
SJR: 2.646
SNIP: 1.573

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

1.984

10% from 2018

Impact factor for Rheumatology International from 2016 - 2019
Year Value
2019 1.984
2018 2.2
2017 1.952
2016 1.824
graph view Graph view
table view Table view

4.0

14% from 2019

CiteRatio for Rheumatology International from 2016 - 2020
Year Value
2020 4.0
2019 3.5
2018 3.5
2017 3.6
2016 3.8
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has decreased by 10% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has increased by 14% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

0.806

17% from 2019

SJR for Rheumatology International from 2016 - 2020
Year Value
2020 0.806
2019 0.686
2018 0.83
2017 0.906
2016 0.724
graph view Graph view
table view Table view

1.015

38% from 2019

SNIP for Rheumatology International from 2016 - 2020
Year Value
2020 1.015
2019 0.737
2018 0.895
2017 0.864
2016 0.795
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has increased by 17% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 38% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Rheumatology International

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Springer

Rheumatology International

RHEUMATOLOGY INTERNATIONAL is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases. It is designed to serve the international and interdisciplinary group of workers involved in problems of rheumatic di...... Read More

Rheumatology

Immunology and Allergy

Medicine

i
Last updated on
14 Jun 2020
i
ISSN
0172-8172
i
Impact Factor
Medium - 0.828
i
Acceptance Rate
55%
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
SPBASIC
i
Citation Type
Author Year
(Blonder et al, 1982)
i
Bibliography Example
Beenakker CWJ (2006) Specular andreev reflection in graphene. Phys Rev Lett 97(6):067,007, URL 10.1103/PhysRevLett.97.067007

Top papers written in this journal

Journal Article DOI: 10.1007/S00296-002-0237-4
Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis

Abstract:

Objective. To investigate differences between HLA-B27– and HLA-B27+ patients with ankylosing spondylitis (AS). Methods. A total of 1080 patients with AS responded to a questionnaire containing 30 questions; 945 (87.5%) knew their HLA-B27 status, 10% of them being B27–. Results. The average age at disease onset was 27.7 yea... Objective. To investigate differences between HLA-B27– and HLA-B27+ patients with ankylosing spondylitis (AS). Methods. A total of 1080 patients with AS responded to a questionnaire containing 30 questions; 945 (87.5%) knew their HLA-B27 status, 10% of them being B27–. Results. The average age at disease onset was 27.7 years in B27– and 24.8 years in B27+ AS (P 40 years) was significantly greater among B27– (13%) than among B27+ (5%) patients with AS. There is a difference in average age at disease onset between male (25.7 years) and female (24.2 years) AS patients, and no difference between patients with primary AS and AS associated with psoriasis, inflammatory bowel disease, or reactive arthritis. Acute anterior uveitis was significantly less frequent in B27– (26%) than in B27+ (41%) patients with AS. Conclusions. This study of a much larger number of B27– AS patients than have been studied previously confirms earlier reports indicating a significantly older average age at disease onset and a less frequent prevalence of acute anterior uveitis in B27– than in B27+ AS. The frequency of late disease onset (after 40 years of age) is significantly higher in B27– AS. We provide the first report on significant differences in the distribution curves for the age at disease onset and for the age at diagnosis between B27–and B27+ patients with AS. The average delay between the first spondyloarthritic symptoms and the diagnosis is significantly longer in B27– than in B27+ AS. The frequency of juvenile disease onset (before age 16 years) is nearly the same, irrespective of the B27 status. read more read less

Topics:

Age of onset (61%)61% related to the paper, HLA-B27 (55%)55% related to the paper, Ankylosing spondylitis (51%)51% related to the paper, Spondylitis (50%)50% related to the paper
754 Citations
Journal Article DOI: 10.1007/S00296-011-1999-3
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
Armen Yuri Gasparyan1, Lilit Ayvazyan2, Heather L. Blackmore3, George D. Kitas1, George D. Kitas4

Abstract:

Review articles comprehensively covering a specific topic are crucial for successful research and academic projects. Most editors consider review articles for special and regular issues of journals. Writing a review requires deep knowledge and understanding of a field. The aim of this review is to analyze the main steps in wr... Review articles comprehensively covering a specific topic are crucial for successful research and academic projects. Most editors consider review articles for special and regular issues of journals. Writing a review requires deep knowledge and understanding of a field. The aim of this review is to analyze the main steps in writing a narrative biomedical review and to consider points that may increase the chances of success. We performed a comprehensive search through MEDLINE, EMBASE, Scopus, and Web of Science using the following keywords: review of the literature, narrative review, title, abstract, authorship, ethics, peer review, research methods, medical writing, scientific writing, and writing standards. Opinions expressed in the review are also based on personal experience as authors, peer reviewers, and editors. read more read less

Topics:

Scientific writing (63%)63% related to the paper, Medical writing (56%)56% related to the paper, Peer review (53%)53% related to the paper
View PDF
461 Citations
Journal Article DOI: 10.1007/BF00541514
The visual analogue scale: its use in pain measurement.

Abstract:

Use of pain rating scales, especially the visual analogue scale (VAS), has increased dramatically in the last decade. Consideration of the VAS in terms of its physical structure and the patient's behaviour when confronted with the scale, casts doubt on its validity. It is nonlinear and prone to bias which limits its use as a ... Use of pain rating scales, especially the visual analogue scale (VAS), has increased dramatically in the last decade. Consideration of the VAS in terms of its physical structure and the patient's behaviour when confronted with the scale, casts doubt on its validity. It is nonlinear and prone to bias which limits its use as a serial measure of pain severity. Measuring pain intensity alone imposes further limitations. The McGill Pain Questionnaire measuring several dimensions of pain appears to be a better alternative. read more read less

Topics:

McGill Pain Questionnaire (65%)65% related to the paper, Visual analogue scale (60%)60% related to the paper
399 Citations
open accessOpen access Journal Article DOI: 10.1007/S00296-011-2263-6
A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity
Philip G. Conaghan1

Abstract:

Non-steroidal anti-inflammatory drugs (NSAIDs) represent a diverse class of drugs and are among the most commonly used analgesics for arthritic pain worldwide, though long-term use is associated with a spectrum of adverse effects. The introduction of cyclooxygenase-2-selective NSAIDs early in the last decade offered an altern... Non-steroidal anti-inflammatory drugs (NSAIDs) represent a diverse class of drugs and are among the most commonly used analgesics for arthritic pain worldwide, though long-term use is associated with a spectrum of adverse effects. The introduction of cyclooxygenase-2-selective NSAIDs early in the last decade offered an alternative to traditional NSAIDs with similar efficacy and improved gastrointestinal tolerability; however, emerging concerns about cardiovascular safety resulted in the withdrawal of two agents (rofecoxib and valdecoxib) in the mid-2000s and, subsequently, in an overall reduction in NSAID use. It is now understood that all NSAIDs are associated with some varying degree of gastrointestinal and cardiovascular risk. Guidelines still recommend their use, but little is known of how patients use these agents. While strategies and guidelines aimed at reducing NSAID-associated complications exist, there is a need for evidence-based algorithms combining cardiovascular and gastrointestinal factors that can be used to aid treatment decisions at an individual patient level. read more read less
View PDF
314 Citations
Journal Article DOI: 10.1007/S00296-004-0485-6
Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.
Ayhan Kamanli1, Arzu Kaya1, Ozge Ardicoglu1, Salih Ozgocmen1, F. Ozkurt Zengin1, Y. Bayık1

Abstract:

Background: Myofascial pain syndrome (MPS) is one of the most common causes of chronic musculoskeletal pain. Several methods have been recommended for the inactivation of trigger points (TrP). Objectives: This prospective, single-blind study was proposed to compare TrP injection with botulinum toxin type A (BTX-A) to dry need... Background: Myofascial pain syndrome (MPS) is one of the most common causes of chronic musculoskeletal pain. Several methods have been recommended for the inactivation of trigger points (TrP). Objectives: This prospective, single-blind study was proposed to compare TrP injection with botulinum toxin type A (BTX-A) to dry needling and lidocaine injection in MPS. Methods: Eighty-seven trigger points (cervical and/or periscapular regions) in 23 female and six male patients with MPS were treated and randomly assigned to three groups: lidocaine injection (n=10, 32 TrP), dry needling (n=10, 33 TrP), and BTX-A injection (n=9, 22 TrP). Outcome measures: Clinical assessment including cervical range of motion, TrP pain pressure threshold (PPT), pain scores (PS), and visual analog scales for pain, fatigue, and work disability were evaluated at entry and the end of the 4th week. Additionally, depression and anxiety were evaluated with the Hamilton depression and anxiety rating scales, and quality of life was assessed using the Nottingham health profile (NHP). The subjects were also asked to describe side effects. Injection procedure: One milliliter of 0.5% lidocaine was administered to each TrP in the lidocaine injection group, 10–20 IU of BTX-A to each TrP in the BTX-A group, and dry needling to each TrP in the last group, followed by stretching of the muscle groups involved. The patients were instructed to continue their home exercise programs. Results: Pain pressure thresholds and PS significantly improved in all three groups. In the lidocaine group, PPT values were significantly higher than in the dry needle group, and PS were significantly lower than in both the BTX-A and dry needle groups. In all, visual analog scores significantly decreased in the lidocaine injection and BTX-A groups and did not significantly change in the dry needle group. Disturbance during the injection procedure was lowest in the lidocaine injection group. Quality of life scores assessed by NHP significantly improved in the lidocaine and BTX-A groups but not in the dry needle group. Depression and anxiety scores significantly improved only in the BTX-A-injected group. Conclusions: Injection is more practical and rapid, since it causes less disturbance than dry needling and is more cost effective than BTX-A injection, and seems the treatment of choice in MPS. On the other hand, BTX-A could be selectively used in MPS patients resistant to conventional treatments. read more read less

Topics:

Dry needling (61%)61% related to the paper, Myofascial pain syndrome (58%)58% related to the paper, Lidocaine (53%)53% related to the paper, Local anesthetic (51%)51% related to the paper, Injection Procedure (50%)50% related to the paper
311 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Rheumatology International.

It automatically formats your research paper to Springer formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Rheumatology International format uses SPBASIC citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Rheumatology International in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Rheumatology International guidelines and auto format it.

2. Do you follow the Rheumatology International guidelines?

Yes, the template is compliant with the Rheumatology International guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Rheumatology International?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Rheumatology International citation style.

4. Can I use the Rheumatology International templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Rheumatology International.

5. Can I use a manuscript in Rheumatology International that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Rheumatology International that you can download at the end.

6. How long does it usually take you to format my papers in Rheumatology International?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Rheumatology International.

7. Where can I find the template for the Rheumatology International?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Rheumatology International's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Rheumatology International's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Rheumatology International an online tool or is there a desktop version?

SciSpace's Rheumatology International is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Rheumatology International?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Rheumatology International?”

11. What is the output that I would get after using Rheumatology International?

After writing your paper autoformatting in Rheumatology International, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Rheumatology International's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Rheumatology International?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Rheumatology International. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Rheumatology International?

The 5 most common citation types in order of usage for Rheumatology International are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Rheumatology International?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Rheumatology International's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Rheumatology International in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Rheumatology International Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Rheumatology International formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template